{"nct_id":"NCT05388669","title":"A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2022-08-05","start_date_type":"ACTUAL","primary_completion_date":"2024-01-03","primary_completion_date_type":"ACTUAL","completion_date":"2026-06-30","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["JNJ"]}